-
1
-
-
0015504841
-
Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon
-
- 204
-
Said, S. I.; Mutt, V. Isolation from porcine-intestinal wall of a vasoactive octacosapeptide related to secretin and to glucagon Eur. J. Biochem. 1972, 13, 199-204
-
(1972)
Eur. J. Biochem.
, vol.13
, pp. 199
-
-
Said, S.I.1
Mutt, V.2
-
2
-
-
0035033922
-
Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease
-
- 568
-
Delgado, M.; Abad, C.; Martinez, C.; Leceta, J.; Gomariz, R. P. Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease Nat. Med. 2001, 7, 563-568
-
(2001)
Nat. Med.
, vol.7
, pp. 563
-
-
Delgado, M.1
Abad, C.2
Martinez, C.3
Leceta, J.4
Gomariz, R.P.5
-
3
-
-
0033964778
-
Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: Relevance to neuroprotection in Parkinson's disease
-
- 262
-
Offen, D.; Sherki, Y.; Melamed, E. Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: Relevance to neuroprotection in Parkinson's disease Brain Res. 2000, 854 (1) 257-262
-
(2000)
Brain Res.
, vol.854
, Issue.1
, pp. 257
-
-
Offen, D.1
Sherki, Y.2
Melamed, E.3
-
4
-
-
0038322494
-
Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation
-
- 946
-
Delgado, M.; Ganea, D. Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation FASEB J. 2003, 17, 944-946
-
(2003)
FASEB J.
, vol.17
, pp. 944
-
-
Delgado, M.1
Ganea, D.2
-
5
-
-
84890479530
-
Vasoactive Intestinal peptide (VIP) and VIP receptors - elucidation of structure and function for therapeutic applications
-
- 508
-
Igarashi, H.; Fujimori, N.; Ito, T.; Nakamura, T.; Oono, T.; Nakamure, K.; Suzuki, K.; Jensen, R. T.; Takayanagi, R. Vasoactive Intestinal peptide (VIP) and VIP receptors-elucidation of structure and function for therapeutic applications Intl. J. Clin. Med. 2011, 2, 500-508
-
(2011)
Intl. J. Clin. Med.
, vol.2
, pp. 500
-
-
Igarashi, H.1
Fujimori, N.2
Ito, T.3
Nakamura, T.4
Oono, T.5
Nakamure, K.6
Suzuki, K.7
Jensen, R.T.8
Takayanagi, R.9
-
6
-
-
0026511295
-
Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide
-
- 819
-
Ishihara, T.; Shigemoto, R.; Mori, K.; Takahashi, K.; Nagata, S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide Neuron 1992, 8, 811-819
-
(1992)
Neuron
, vol.8
, pp. 811
-
-
Ishihara, T.1
Shigemoto, R.2
Mori, K.3
Takahashi, K.4
Nagata, S.5
-
7
-
-
0027332401
-
The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide
-
- 8
-
Lutz, E. M.; Sheward, W. J.; West, K. M.; Morrow, J. A.; Fink, G.; Harmar, A. J. The VIP2 receptor: Molecular characterisation of a cDNA encoding a novel receptor for vasoactive intestinal peptide FEBS Lett. 1993, 334, 3-8
-
(1993)
FEBS Lett.
, vol.334
, pp. 3
-
-
Lutz, E.M.1
Sheward, W.J.2
West, K.M.3
Morrow, J.A.4
Fink, G.5
Harmar, A.J.6
-
8
-
-
84859698659
-
Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1
-
- 17
-
Harmar, A. J.; Fahrenkrug, J.; Gozes, I.; Laburthe, M.; May, V.; Pisegna, J. R.; Vaudry, D.; Vaudry, H.; Waschek, J. A.; Said, S. I. Pharmacology and functions of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide: IUPHAR Review 1 Br. J. Pharmacol. 2012, 166, 4-17
-
(2012)
Br. J. Pharmacol.
, vol.166
, pp. 4
-
-
Harmar, A.J.1
Fahrenkrug, J.2
Gozes, I.3
Laburthe, M.4
May, V.5
Pisegna, J.R.6
Vaudry, D.7
Vaudry, H.8
Waschek, J.A.9
Said, S.I.10
-
9
-
-
0030060951
-
Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat
-
- 770
-
Bertrand, G.; Puech, R.; Maisonnasse, Y.; Bockaert, J.; Loubatieres-Mariani, M. M. Comparative effects of PACAP and VIP on pancreatic endocrine secretions and vascular resistance in rat Br. J. Pharmacol. 1996, 117, 764-770
-
(1996)
Br. J. Pharmacol.
, vol.117
, pp. 764
-
-
Bertrand, G.1
Puech, R.2
Maisonnasse, Y.3
Bockaert, J.4
Loubatieres-Mariani, M.M.5
-
10
-
-
34548444547
-
Role of VIP and PACAP in Islet Function
-
- 1813
-
Winzell, M. S.; Ahren, B. Role of VIP and PACAP in Islet Function Peptides 2007, 28, 1805-1813
-
(2007)
Peptides
, vol.28
, pp. 1805
-
-
Winzell, M.S.1
Ahren, B.2
-
11
-
-
0036312399
-
2 agonist enhances glucose-induced insulin release and glucose disposal: A potential therapy for type 2 diabetes
-
- 1460
-
2 agonist enhances glucose-induced insulin release and glucose disposal: A potential therapy for type 2 diabetes Diabetes 2002, 51, 1453-1460
-
(2002)
Diabetes
, vol.51
, pp. 1453
-
-
Tsutsumi, M.1
Claus, T.H.2
Liang, Y.3
Li, Y.4
Yang, L.5
Zhu, J.6
-
12
-
-
0028351892
-
Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells
-
- 2683
-
Inagaki, N.; Yoshida, H.; Mizuta, M.; Mizuno, N.; Fujii, Y.; Gonoi, T.; Miyazaki, J.; Seino, S. Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells Proc. Natl. Acad. Sci. 1994, 91, 2679-2683
-
(1994)
Proc. Natl. Acad. Sci.
, vol.91
, pp. 2679
-
-
Inagaki, N.1
Yoshida, H.2
Mizuta, M.3
Mizuno, N.4
Fujii, Y.5
Gonoi, T.6
Miyazaki, J.7
Seino, S.8
-
13
-
-
0036772780
-
Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate
-
- 4006
-
Asnicar, M. A.; Koster, A.; Heiman, M. L.; Tinsley, F.; Smith, D. P.; Galbreath, E. Vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating peptide receptor 2 deficiency in mice results in growth retardation and increased basal metabolic rate Endocrinology 2002, 143, 3994-4006
-
(2002)
Endocrinology
, vol.143
, pp. 3994
-
-
Asnicar, M.A.1
Koster, A.2
Heiman, M.L.3
Tinsley, F.4
Smith, D.P.5
Galbreath, E.6
-
14
-
-
0018171931
-
Vasoactive Intestinal Peptide in Man: Pharmacokinetics, Metabolic and Circulatory Effects
-
- 1053
-
Domschke, S.; Domschke, W.; Bloom, S. R. Vasoactive Intestinal Peptide in Man: Pharmacokinetics, Metabolic and Circulatory Effects Gut 1978, 19, 1049-1053
-
(1978)
Gut
, vol.19
, pp. 1049
-
-
Domschke, S.1
Domschke, W.2
Bloom, S.R.3
-
15
-
-
61649120635
-
Recent progress of synthetic studies to peptide and peptidomimetic cyclization
-
- 1542
-
Jiang, S.; Li, Z.; Ding, K.; Roller, P. P. Recent progress of synthetic studies to peptide and peptidomimetic cyclization Curr. Org. Chem 2008, 12, 1502-1542
-
(2008)
Curr. Org. Chem
, vol.12
, pp. 1502
-
-
Jiang, S.1
Li, Z.2
Ding, K.3
Roller, P.P.4
-
16
-
-
0032542374
-
Highly efficient synthesis of covalently cross-linked peptide helices by ring-closing metathesis
-
- 3284
-
Blackwell, H. E.; Grubbs, R. H. Highly efficient synthesis of covalently cross-linked peptide helices by ring-closing metathesis Angew. Chem., Int. Ed. 1998, 37, 3281-3284
-
(1998)
Angew. Chem., Int. Ed.
, vol.37
, pp. 3281
-
-
Blackwell, H.E.1
Grubbs, R.H.2
-
17
-
-
0034697649
-
An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides
-
- 5892
-
Schafmeister, C. E.; Po, J.; Verdine, G. L. An all-hydrocarbon cross-linking system for enhancing the helicity and metabolic stability of peptides J. Am. Chem. Soc. 2000, 122, 5891-5892
-
(2000)
J. Am. Chem. Soc.
, vol.122
, pp. 5891
-
-
Schafmeister, C.E.1
Po, J.2
Verdine, G.L.3
-
18
-
-
0035838887
-
Ring-closing metathesis of olefinic peptides: Design, synthesis, and structural characterization of macrocyclic helical peptides
-
- 5302
-
Blackwell, H. E.; Sadowsky, J. D.; Howard, R. J.; Sampson, J. N.; Chao, J. A.; Steinmetz, W. E.; O'Leary, D. J.; Grubbs, R. H. Ring-closing metathesis of olefinic peptides: Design, synthesis, and structural characterization of macrocyclic helical peptides J. Org. Chem. 2001, 66, 5291-5302
-
(2001)
J. Org. Chem.
, vol.66
, pp. 5291
-
-
Blackwell, H.E.1
Sadowsky, J.D.2
Howard, R.J.3
Sampson, J.N.4
Chao, J.A.5
Steinmetz, W.E.6
O'leary, D.J.7
Grubbs, R.H.8
-
19
-
-
79958086652
-
Synthesis of all-hydrocarbon stapled a-helical peptides by ring-closing olefin metathesis
-
- 771
-
Kim, Y.-W.; Grossmann, T. N.; Verdine, G. L. Synthesis of all-hydrocarbon stapled a-helical peptides by ring-closing olefin metathesis Nat. Protoc. 2011, 6, 761-771
-
(2011)
Nat. Protoc.
, vol.6
, pp. 761
-
-
Kim, Y.-W.1
Grossmann, T.N.2
Verdine, G.L.3
-
20
-
-
84864401719
-
All-hydrocarbon stapled peptides as synthetic cell-accessible mini-proteins
-
- e47
-
Verdine, G. L.; Hilinski, G. J. All-hydrocarbon stapled peptides as synthetic cell-accessible mini-proteins Drug Discovery Today 2012, 9, e41-e47
-
(2012)
Drug Discovery Today
, vol.9
, pp. 41
-
-
Verdine, G.L.1
Hilinski, G.J.2
-
21
-
-
77956331314
-
Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges
-
- 6420
-
Murage, E. N.; Gao, G.; Bisello, A.; Ahn, J.-M. Development of potent glucagon-like peptide-1 agonists with high enzyme stability via introduction of multiple lactam bridges J. Med. Chem. 2010, 53, 6412-6420
-
(2010)
J. Med. Chem.
, vol.53
, pp. 6412
-
-
Murage, E.N.1
Gao, G.2
Bisello, A.3
Ahn, J.-M.4
-
22
-
-
4444291734
-
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
-
- 1470
-
Walensky, L. D.; Kung, A. L.; Escher, I.; Malia, T. J.; Barbuto, S.; Wright, R. D.; Wagner, G.; Verdine, G. L.; Korsmeyer, S. J. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix Science 2004, 305, 1466-1470
-
(2004)
Science
, vol.305
, pp. 1466
-
-
Walensky, L.D.1
Kung, A.L.2
Escher, I.3
Malia, T.J.4
Barbuto, S.5
Wright, R.D.6
Wagner, G.7
Verdine, G.L.8
Korsmeyer, S.J.9
-
23
-
-
38949140180
-
Dual role of proapoptotic BAD in insulin secretion and beta cell survival
-
- 153
-
Danial, N. N.; Walensky, L. D.; Zhang, C. Y.; Choi, C. S.; Fisher, J. K.; Molina, A. J.; Datta, S. R.; Pitter, K. L.; Bird, G. H.; Wikstrom, J. D.; Deeney, J. T.; Robertson, K.; Morash, J.; Kulkarni, A.; Neschen, S.; Kim, S.; Greenberg, M. E.; Corkey, B. E.; Shirihai, O. S.; Shulman, G. I.; Lowell, B. B.; Korsmeyer, S. J. Dual role of proapoptotic BAD in insulin secretion and beta cell survival Nat. Med. 2008, 14, 144-153
-
(2008)
Nat. Med.
, vol.14
, pp. 144
-
-
Danial, N.N.1
Walensky, L.D.2
Zhang, C.Y.3
Choi, C.S.4
Fisher, J.K.5
Molina, A.J.6
Datta, S.R.7
Pitter, K.L.8
Bird, G.H.9
Wikstrom, J.D.10
Deeney, J.T.11
Robertson, K.12
Morash, J.13
Kulkarni, A.14
Neschen, S.15
Kim, S.16
Greenberg, M.E.17
Corkey, B.E.18
Shirihai, O.S.19
Shulman, G.I.20
Lowell, B.B.21
Korsmeyer, S.J.22
more..
-
24
-
-
70449671729
-
Direct inhibition of the NOTCH transcription factor complex
-
- 188
-
Moellering, R. E.; Cornejo, M.; Davis, T. N.; Del Bianco, C.; Aster, J. C.; Blacklow, S. C.; Kung, A. L.; Gilliland, D. G.; Verdine, G. L.; Bradner, J. E. Direct inhibition of the NOTCH transcription factor complex Nature 2009, 462, 182-188
-
(2009)
Nature
, vol.462
, pp. 182
-
-
Moellering, R.E.1
Cornejo, M.2
Davis, T.N.3
Del Bianco, C.4
Aster, J.C.5
Blacklow, S.C.6
Kung, A.L.7
Gilliland, D.G.8
Verdine, G.L.9
Bradner, J.E.10
-
25
-
-
77956294635
-
Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic
-
- 14098
-
Bird, G. H.; Madani, N.; Perry, A. F.; Princiotto, A. M.; Supko, J. G.; He, X.; Gavathiotis, E.; Sodroski, J. G.; Walensky, L. D. Hydrocarbon double-stapling remedies the proteolytic instability of a lengthy peptide therapeutic Proc. Natl. Acad. Sci. 2010, 107, 14093-14098
-
(2010)
Proc. Natl. Acad. Sci.
, vol.107
, pp. 14093
-
-
Bird, G.H.1
Madani, N.2
Perry, A.F.3
Princiotto, A.M.4
Supko, J.G.5
He, X.6
Gavathiotis, E.7
Sodroski, J.G.8
Walensky, L.D.9
-
26
-
-
70349308687
-
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
-
- 757
-
Day, J. W.; Ottaway, N.; Patterson, J. T.; Gelfanov, V.; Smiley, D.; Gidda, J.; Findeisen, H.; Bruemmer, D.; Drucker, D. J.; Chaudhary, N.; Holland, J.; Hembree, J.; Abplanalp, W.; Grant, E.; Ruehl, J.; Wilson, H.; Kirchner, H.; Lockie, S. H.; Hofmann, S.; Woods, S. C.; Nogueiras, R.; Pfluger, P. T.; Perez-Tilve, D.; DiMarchi, R.; Tschöp, M. H. A new glucagon and GLP-1 co-agonist eliminates obesity in rodents Nat. Chem. Biol. 2009, 10, 749-757
-
(2009)
Nat. Chem. Biol.
, vol.10
, pp. 749
-
-
Day, J.W.1
Ottaway, N.2
Patterson, J.T.3
Gelfanov, V.4
Smiley, D.5
Gidda, J.6
Findeisen, H.7
Bruemmer, D.8
Drucker, D.J.9
Chaudhary, N.10
Holland, J.11
Hembree, J.12
Abplanalp, W.13
Grant, E.14
Ruehl, J.15
Wilson, H.16
Kirchner, H.17
Lockie, S.H.18
Hofmann, S.19
Woods, S.C.20
Nogueiras, R.21
Pfluger, P.T.22
Perez-Tilve, D.23
Dimarchi, R.24
Tschöp, M.H.25
more..
-
27
-
-
84874027448
-
Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity
-
- 302
-
Okamoto, T.; Zobel, K.; Fedorova, A.; Quan, C.; Yang, H.; Fairbrother, W. J.; Huang, D. C. S.; Smith, B. J.; Deshayes, K.; Czabotar, P. E. Stabilizing the pro-apoptotic BimBH3 helix (BimSAHB) does not necessarily enhance affinity or biological activity ACS Chem. Biol. 2013, 8, 297-302
-
(2013)
ACS Chem. Biol.
, vol.8
, pp. 297
-
-
Okamoto, T.1
Zobel, K.2
Fedorova, A.3
Quan, C.4
Yang, H.5
Fairbrother, W.J.6
Huang, D.C.S.7
Smith, B.J.8
Deshayes, K.9
Czabotar, P.E.10
-
28
-
-
0033792032
-
Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor
-
- 1549
-
Moreno, D.; Gourlet, P.; De Neef, P.; Cnudde, J.; Waelbroeck, C. M.; Robberecht, P. Development of selective agonists and antagonists for the human vasoactive intestinal polypeptide VPAC(2) receptor Peptides 2000, 21, 1543-1549
-
(2000)
Peptides
, vol.21
, pp. 1543
-
-
Moreno, D.1
Gourlet, P.2
De Neef, P.3
Cnudde, J.4
Waelbroeck, C.M.5
Robberecht, P.6
-
29
-
-
0038532265
-
Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide
-
- 10281
-
Yung, S. L.; Dela Cruz, F.; Hamren, S.; Zhu, J.; Tsutsumi, M.; Bloom, J. W.; Caudle, M.; Roczniak, S.; Todd, T.; Lemoine, L.; MacDougal, M.; Shanafelt, A. B.; Pan, C. Q. Generation of highly selective VPAC2 receptor agonists by high throughput mutagenesis of vasoactive intestinal peptide and pituitary adenylate cyclase-activating peptide J. Biol. Chem. 2003, 278, 10273-10281
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 10273
-
-
Yung, S.L.1
Dela Cruz, F.2
Hamren, S.3
Zhu, J.4
Tsutsumi, M.5
Bloom, J.W.6
Caudle, M.7
Roczniak, S.8
Todd, T.9
Lemoine, L.10
Macdougal, M.11
Shanafelt, A.B.12
Pan, C.Q.13
-
30
-
-
35348845217
-
Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor
-
- 13947
-
Parthier, C.; Kleinschmidt, M.; Neumann, P.; Rudolph, R.; Manhart, S.; Schlenzig, D.; Fanghanel, J.; Rahfeld, J.-U.; Demuth, H.-U.; Stubbs, M. T. Crystal structure of the incretin-bound extracellular domain of a G protein-coupled receptor Proc. Natl. Acad. Sci 2007, 104, 13942-13947
-
(2007)
Proc. Natl. Acad. Sci
, vol.104
, pp. 13942
-
-
Parthier, C.1
Kleinschmidt, M.2
Neumann, P.3
Rudolph, R.4
Manhart, S.5
Schlenzig, D.6
Fanghanel, J.7
Rahfeld, J.-U.8
Demuth, H.-U.9
Stubbs, M.T.10
-
31
-
-
84890448207
-
-
Crystal Structure of the Extracellular Domain of Human Vasoactive Intestinal Polypeptide Receptor 2.
-
Crystal Structure of the Extracellular Domain of Human Vasoactive Intestinal Polypeptide Receptor 2. http://www.pdb.org/pdb/explore/explore.do? structureId=2X57.
-
-
-
-
32
-
-
0030052889
-
Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide
-
- 432
-
Gozes, I.; Bardea, A.; Reshef, A.; Zamostiano, R.; Zhukovsky, S.; Rubinraut, S.; Fridkin, M.; Brenneman, D. E. Neuroprotective strategy for Alzheimer disease: Intranasal administration of a fatty neuropeptide Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 427-432
-
(1996)
Proc. Natl. Acad. Sci. U.S.A.
, vol.93
, pp. 427
-
-
Gozes, I.1
Bardea, A.2
Reshef, A.3
Zamostiano, R.4
Zhukovsky, S.5
Rubinraut, S.6
Fridkin, M.7
Brenneman, D.E.8
-
33
-
-
0034604577
-
Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist: Alanine scanning and molecular modeling of the peptide
-
- 24012
-
Nicole, P.; Lins, L.; Rouyer-Fessard, C.; Drouot, C.; Fulcrand, P.; Thomas, A.; Couvineau, A.; Martinez, A.; Brasseur, R.; Laburthe, M. Identification of key residues for interaction of vasoactive intestinal peptide with human VPAC1 and VPAC2 receptors and development of a highly selective VPAC1 receptor agonist: Alanine scanning and molecular modeling of the peptide J. Biol. Chem. 2000, 275, 24003-24012
-
(2000)
J. Biol. Chem.
, vol.275
, pp. 24003
-
-
Nicole, P.1
Lins, L.2
Rouyer-Fessard, C.3
Drouot, C.4
Fulcrand, P.5
Thomas, A.6
Couvineau, A.7
Martinez, A.8
Brasseur, R.9
Laburthe, M.10
-
34
-
-
84862908454
-
Structure of the stapled p53 peptide bound to Mdm2
-
- 106
-
Baek, S.; Kutchukian, P. S.; Verdine, G. L.; Huber, R.; Holak, T. A.; Lee, K. W.; Popowicz, G. M. Structure of the stapled p53 peptide bound to Mdm2 J. Am. Chem. Soc. 2012, 134, 103-106
-
(2012)
J. Am. Chem. Soc.
, vol.134
, pp. 103
-
-
Baek, S.1
Kutchukian, P.S.2
Verdine, G.L.3
Huber, R.4
Holak, T.A.5
Lee, K.W.6
Popowicz, G.M.7
-
35
-
-
0031809309
-
Stabilization of vasoactive intestinal peptide by lipids
-
- 758
-
Golobov, G.; Noda, Y.; Sherman, S.; Rubinstein, I.; Baranowska- Kortylewicz, J.; Paul, S. Stabilization of vasoactive intestinal peptide by lipids J. Pharmacol. Exp. Ther. 1998, 285, 753-758
-
(1998)
J. Pharmacol. Exp. Ther.
, vol.285
, pp. 753
-
-
Golobov, G.1
Noda, Y.2
Sherman, S.3
Rubinstein, I.4
Baranowska-Kortylewicz, J.5
Paul, S.6
-
36
-
-
84855584802
-
Stapled peptides for intracellular drug targets
-
- 33
-
Verdine, G. L.; Hilinski, G. J. Stapled peptides for intracellular drug targets Methods Enzymol. 2012, 503, 3-33
-
(2012)
Methods Enzymol.
, vol.503
, pp. 3
-
-
Verdine, G.L.1
Hilinski, G.J.2
-
37
-
-
84876702107
-
NAr chemistry approach to unprotected peptide stapling
-
NAr chemistry approach to unprotected peptide stapling J. Am. Chem. Soc. 2013, 135, 5946-5949
-
(2013)
J. Am. Chem. Soc.
, vol.135
, pp. 5946-5949
-
-
Spokoyny, A.M.1
Zou, Y.2
Ling, J.J.3
Yu, H.4
Lin, Y.-S.5
Pentelute, B.L.6
|